Tue, May 28, 2024
Natco Pharma reported a 40 per cent rise in its profit after tax (PAT) to Rs 386 core in the fourth quarter from Rs 276 crore Year-on-Year (YoY). The pharma company's revenue from operations was up by 19 per cent to Rs 1,068 crore in the quarter under review from Rs 898 crore in the same quarter last fiscal.
More >
Wed, Feb 14, 2024
Jain Saab's GEMS: Why did Sandeep Jain choose Natco Pharma today? Know the company's fundamentals, bullish triggers and targets from Sandeep Jain...
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.